Loading clinical trials...
Loading clinical trials...
A Randomized, Multicenter, Double-blind, Vehicle-controlled Study to Evaluate the Safety and Efficacy of FMX103 1.5% Topical Minocycline Foam Compared to Vehicle in the Treatment of Facial Papulopustular Rosacea (FX2016-12)
Conditions
Interventions
FMX103 minocycline foam 1.5%
Vehicle foam
Locations
46
United States
Foamix Investigational Site # 207
Glendale, Arizona, United States
Foamix Investigational Site # 202
Hot Springs, Arkansas, United States
Foamix Investigational Site # 222
Rogers, Arkansas, United States
Foamix Investigational Site #244
Encino, California, United States
Foamix Investigational Site #249
Huntington Beach, California, United States
Foamix Investigational Site # 226
Los Angeles, California, United States
Start Date
June 1, 2017
Primary Completion Date
July 2, 2018
Completion Date
July 31, 2018
Last Updated
January 7, 2021
Lead Sponsor
Vyne Therapeutics Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions